SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥145.53+CN¥2.64 (+1.85%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 16.17% below the high.
Loading market information…
SHH · 688617.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 03:29 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
APT Medical Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.57% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
APT Medical Inc.’s forward annual dividend is CN¥1.00 per share, paid annual. The forward yield is 0.36% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
APT Medical Inc.’s next earnings report is currently expected on Mar 30, 2027, with estimated earnings per share of CN¥1.65. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow APT Medical Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:59 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 |
|---|
| Aug 22, 2025 |
| CN¥1.72 |
| CN¥649.53M |
| Q1 2025 | Apr 23, 2025 | CN¥1.88 | CN¥564.28M+0.05% vs estimate |
|---|
| Q4 2024 | Feb 24, 2025 | CN¥1.49-14.37% vs estimate | CN¥540.97M-0.01% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥145.53+CN¥2.64 (+1.85%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 16.17% below the high.
CN¥49.03+CN¥0.41 (+0.84%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.52% below the high.
HK$51.05+HK$0.40 (+0.79%)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 36.94% below the high.
CN¥179.20+CN¥0.20 (+0.11%)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 20.18% below the high.
CN¥12.03+CN¥0.06 (+0.5%)
Lepu Medical Technology (Beijing) Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.31% below the high.
CN¥85.50+CN¥3.10 (+3.76%)
Shanghai MicroPort Endovascular MedTech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.21% below the high.
CN¥13.22-CN¥0.04 (-0.3%)
Sino Medical Sciences Technology Inc.’s quoted price sits in the lower half of its reported 52-week range, 49.66% below the high.
CN¥39.08+CN¥0.33 (+0.85%)
Nanjing Vishee Medical Technology Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 45.93% below the high.
